|
1. FDA to reexamine infant RSV therapies Full story
2. Mail-order drug access threatened by USPS delivery slowdowns: Report Full story
3. DSH pressure is mounting — act now to protect 340B eligibility and keep your pharmacy profitable and compliant. Learn more
here.
4. Pfizer inks $2B deal for early-stage GLP-1 Full story
5. GLP-1s may not affect obesity-related cancer risk: Study Full story
6. From detection to prevention: The 4 controls hospitals are implementing to curb diversion here.
7. 1 dose as effective as 2 for HPV vaccine: 5 study notes Full story
8. CVS unveils AI platform, raises 2025 forecast Full story
9. Former UnitedHealth Group CEO to join Fairview, U of Minnesota merger talks Full story
10. West Virginia sues UnitedHealth's Optum over opioid crisis Full story
11. Trump eyes AI executive order Full story
12. Some pharmacies are speeding approvals + reducing staff friction. See what's driving it here.
Becker's Learning Opportunities
13. Payer specialty drug strategy is changing. Get up to speed here.
14. CMOs, CMIOs and pharmacy leaders are working to transform pain care. Learn how here.
15. Inflammatory drug spend is rising fast. This model lowered total medical costs 8%. See how here.
16. Becker’s resources don’t stop here — explore more
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
